The acquired immunodeficiency syndrome (AIDS) has become a global pandemic with over 366,000 cases reported from 162 counthes. A major focus within our unit has been defining the unique epidemiologic, clinical, virologic and immunologic features of human immunodeficiency virus type 1 (HIV-1) infection in Africa and other tropical countries. In two related studies in Kinshasa, Zaire we demonstrated that AIDS is the leading cause of death with HIV seroprevalence in 43% of adult deaths. We also demonstrated that 40% of 1200 female prostitutes in Kinshasa and 14% of 546 Nigerian prostitutes were HIV-1 seropositive, and that incident infections (3%/yr) were strongly correlated with genital ulcers and chlamydial infections. In studies of perinatal infection, in over 600 children born to HIV infected mothers in Zaire and Haiti, we documented a 28% transmission rate of HIV-1 infection and a cumulative mortality rate of 70% in the first two years of life. Of surviving children during the first year of life a beneficial effect of immunizations against commonly occuring childhood infectious diseases was observed despite the lower immunogenicity in HIV-1 seropositive individuals. In virologic studies we demonstrated that no single diagnostic assay was reliable in diagnosing perinatally acquired HIV infection within the first month of life, but that by 3 months, HIV culture, polymerase chain reaction and lgA each had a high positive predictive value which further improved at 6 and 9 months of age. Additional studies demonstrated the presence of neutralizing antibody to the V3 loop region of HIV-1mn in HIV-infected individuals in the U.S., Zaire and Brazil, but we were unable to document an association between the presence of these neutralizing antibodies and decreased perinatal transmission rates. In contrast, perinatal transmission was independently associated with decreased number of CD4 cells and chorioamnionitis. Additional virologic and immunologic studies further defined the prognostic importance of p24 antigenemia following acid hydrolysis, the role of cytokines, particularly TNF-alpha, and activated T-cell subsets in the natural history and immunopathogenesis of HIV infection. Further studies will continue to examine virologic and immunologic aspects of human retroviral infections internationally.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Intramural Research (Z01)
Project #
1Z01AI000361-09
Application #
3803167
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
9
Fiscal Year
1991
Total Cost
Indirect Cost
City
State
Country
United States
Zip Code
Meya, David; Spacek, Lisa A; Tibenderana, Hilda et al. (2009) Development and evaluation of a clinical algorithm to monitor patients on antiretrovirals in resource-limited settings using adherence, clinical and CD4 cell count criteria. J Int AIDS Soc 12:3
Johnson, Kristine E; Quinn, Thomas C (2008) Update on male circumcision: prevention success and challenges ahead. Curr Infect Dis Rep 10:243-51
Blake, Diane R; Maldeis, Nancy; Barnes, Mathilda R et al. (2008) Cost-effectiveness of screening strategies for Chlamydia trachomatis using cervical swabs, urine, and self-obtained vaginal swabs in a sexually transmitted disease clinic setting. Sex Transm Dis 35:649-55
Chang, Larry William; Kagaayi, Joseph; Nakigozi, Gertrude et al. (2008) Telecommunications and health Care: an HIV/AIDS warmline for communication and consultation in Rakai, Uganda. J Int Assoc Physicians AIDS Care (Chic) 7:130-2
Blake, Diane R; Quinn, Thomas C; Gaydos, Charlotte A (2008) Should asymptomatic men be included in chlamydia screening programs? Cost-effectiveness of chlamydia screening among male and female entrants to a national job training program. Sex Transm Dis 35:91-101
NIMH Collaborative HIV/STD Prevention Trial Group (2007) Formative study conducted in five countries to adapt the community popular opinion leader intervention. AIDS 21 Suppl 2:S91-8
NIMH Collaborative HIV/STD Prevention Trial Group (2007) Sexually transmitted disease and HIV prevalence and risk factors in concentrated and generalized HIV epidemic settings. AIDS 21 Suppl 2:S81-90
NIMH Collaborative HIV/STD Prevention Trial Group (2007) The community popular opinion leader HIV prevention programme: conceptual basis and intervention procedures. AIDS 21 Suppl 2:S59-68
NIMH Collaborative HIV/STD Prevention Trial Group (2007) Ethical issues in the NIMH Collaborative HIV/STD Prevention Trial. AIDS 21 Suppl 2:S69-80
NIMH Collaborative HIV/STD Prevention Trial (2007) Role of the data safety and monitoring board in an international trial. AIDS 21 Suppl 2:S99-102

Showing the most recent 10 out of 123 publications